Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01562899 |
| Title | A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Array BioPharma |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | ITA | GBR | FRA | ESP | CAN | BEL | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Massachusetts General Hospital Mass General 2 | Boston | Massachusetts | 02114 | United States | Details | |
| University of Utah / Huntsman Cancer Institute Huntsman | Salt Lake City | Utah | 84103 | United States | Details | |
| Pfizer Investigative Site | Parkville | Victoria | 3050 | Australia | Details | |
| Pfizer Investigative Site | Leuven | 3000 | Belgium | Details | ||
| Pfizer Investigative Site | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| Pfizer Investigative Site | Toulouse Cedex 9 | 31059 | France | Details | ||
| Pfizer Investigative Site | Napoli | 80131 | Italy | Details | ||
| Pfizer Investigative Site | Barcelona | Catalunya | 08035 | Spain | Details | |
| Pfizer Investigative Site | Sutton | Surrey | SM2 5PT | United Kingdom | Details |